Health-care companies ticked down amid mixed earnings.

Swiss drug maker Roche said first-quarter sales declined amid weak demand for Covid-19 products and currency headwinds but slightly beat analysts expectations.

Shares of medical-device maker Boston Scientific rose after it forecast growth ahead of Wall Street expectations.

Biogen shares rallied after the biopharmaceutical company reported better-than-expected earnings and a hefty increase in sales of its Alzheimer's drug.

Write to Rob Curran at

(END) Dow Jones Newswires

04-24-24 1716ET